Osprey Medical has been cleared by the FDA to market its Avert System, which is used to minimize patient exposure to dye during angiogram or diagnostic heart procedures. A clinical study showed the device was able to lower by as much as 40% the amount of dye used during angiograms while maintaining image quality.
Osprey Medical gets FDA OK for angiogram device
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|